The UCCCC communications team provides timely and interesting stories about research, scientists, and patients at UChicago Medicine. Through a variety of publications and communications — print and electronic — the communications team shares new developments and important information in cancer causes, diagnosis, treatment, and prevention.
If you would like to share your story with the UCCCC, please contact us at email@example.com.
Read our new Answer Cancer newsletter to learn the latest in breakthroughs and activities from the University of Chicago Medicine Comprehensive Cancer Center.
The UChicago Science Life blog serves as a home for community dialogue around cancer care, treatment, and research. UCCCC experts offer their unique perspectives on cancer trends, innovative patient treatments, and scientific discoveries.
The Winter issue of Pathways highlights UChicago's ambitious fundraising campaign, a partnership to use big data to enhance cancer research, celebrating 10 years of Comer Children's Hospital, and much more.
Winter 2015 Pathways to Discovery (PDF)
Cancer Genetics Pioneer Janet Rowley, MD, DSc, 1925-2013
Press release — December 17, 2013
At the UCCCC, our job is to provide hope. There are many ways we do that. It can be the use of our advanced treatment methods or relying on the expertise of our world-class researchers for the latest breakthroughs. But most of all, it is about providing the best in patient care. Watch our videos to learn what sets us apart.
Personalized medicine remains the driving force for UCCCC research. Our annual report details many of the significant accomplishments that reflect our mission to translate basic and clinical research into individualized cancer care.
2014 Annual Report (PDF)
Our 2012-2013 Scientific Report highlights the UCCCC's initiatives to drive personalized therapies, accelerate population research efforts, enhance cancer clinical trials, and improve cancer education. The report also highlights faculty research accomplishments.
2012-2013 Scientific Report (PDF)